Hot Flashes During Androgen Deprivation Therapy With Luteinizing Hormone-Releasing Hormone Agonist Combined With Steroidal or Nonsteroidal Antiandrogen for Prostate Cancer

Urology

Volumn 73, Issue 3, 2009, Pages 635-640

  Sakai, Hideki ^a   Igawa, Tsukasa ^a   Tsurusaki, Toshifumi ^b   Yura, Morishi ^b   Kusaba, Yasuyuki ^b   Hayashi, Mikio ^c   Iwasaki, Shotaro ^d   Hakariya, Hironobu ^e   Hara, Tanetoshi ^f   Kanetake, Hiroshi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b JAPANESE RED CROSS NAGASAKI GENBAKU HOSPITAL   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^d Sasebo Shiritsu Sogo Hospital   (Japan)

^e Ureshino Medical Center   (Japan)

^f Nagasaki Municipal Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; BICALUTAMIDE; CHLORMADINONE; GONADORELIN AGONIST; LEUPRORELIN;

AGED; ANDROGEN DEPRIVATION THERAPY; ANEMIA; ANTIANDROGEN THERAPY; ARTICLE; CANCER HORMONE THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISTRESS SYNDROME; DRUG WITHDRAWAL; HOT FLUSH; HUMAN; INCIDENCE; JAPANESE; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SWEATING;

AGED; ANDROGEN ANTAGONISTS; ANILIDES; ANTINEOPLASTIC AGENTS, HORMONAL; CHLORMADINONE ACETATE; DRUG THERAPY, COMBINATION; GONADOTROPIN-RELEASING HORMONE; HOT FLASHES; HUMANS; LEUPROLIDE; MALE; NITRILES; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; STEROIDS; TOSYL COMPOUNDS;

EID: 60549109867     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.09.013     Document Type: Article

References (16)

1. Stearns V., Ullmer L., Lopez J.F., et al. Hot flushes. Lancet 360 (2002) 1851-1861
2. Holzbeierlein J.M., McLaughlin M.D., and Thrasher J.B. Complications of androgen deprivation therapy for prostate cancer. Curr Opin Urol 14 (2004) 177-183
3. Thorpe S.C., Azmatullah S., Fellows G.J., et al. A prospective, randomized study to compare goserelin acetate (Zoladex) versus cyproterone acetate (Cyprostat) versus a combination of the two in the treatment of metastatic prostatic carcinoma. Eur Urol 29 (1996) 47-54
4. Loprinzi C.L., Michalak J.C., Quella S.K., et al. Megestrol acetate for the prevention of hot flashes. N Engl J Med 331 (1994) 347-352
5. Kotake T., Usami M., Akaza H., et al. Clinical evaluation of bicalutamide (Casodex) in patients with prostate cancer: A double-blind trial of bicalutamide versus chlormadinone acetate. Jpn J Urol Surg 9 (1996) 243-256
6. Hinotsu A., Niimi M., Akaza H., et al. Development of Japanese version of QOL questionnaire for bladder and prostate cancer patients using FACT-Bl and P: Pilot study. Gan To Kagaku Ryoho 26 (1999) 657-666
7. Esper P., Mo F., Chodak G., et al. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology 50 (1997) 920-928
8. Basaria S., Lieb II J., Tang A.M., et al. Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol 56 (2002) 779-786
9. Charig C.R., and Rundle J.S. Flashing: Long-term side effect of orchiectomy in treatment of prostatic carcinoma. Urology 33 (1989) 175-178
10. Carpenter J.S., Andrykowski M.A., Cordova M., et al. Hot flashes in postmenopausal women treated for breast carcinoma: Prevalence, severity, correlates, management, and relation to quality of life. Cancer 82 (1998) 1682-1691
11. Jonler M., Nielsen O.S., Groenvold M., et al. Quality of life in patients with skeletal metastases of prostate cancer and status prior to start of endocrine therapy: Results from the Scandinavian Prostate Cancer Group study 5. Scand J Urol Nephrol 39 (2005) 42-48
12. Morrison J., Martin D., Blair R., et al. The use of medroxyprogesterone acetate for relief of climacteric symptoms. Am J Obstet Gynecol 138 (1980) 99-104
13. Schiff I., Tulchinsky D., Cramer D., et al. Oral medroxyprogesterone in the treatment of menopausal symptoms. JAMA 244 (1980) 1443-1445
14. Goodwin J.W., Green S.J., Moinpour C.M., et al. Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group study 9626. J Clin Oncol 26 (2008) 1650-1656
15. Tsai C.L., Matsumura K., and Nakayama T. Effects of progesterone on thermosensitive neurons in preoptic slice preparations. Neurosci Lett 86 (1988) 56-60
16. Prostate Cancer Trialists' Collaborative Group. Maximum androgen blockade in advanced prostate cancer: An overview of the randomised trials. Lancet 355 (2000) 1491-1498